Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Roxithromycin has antiallergic activity

Sep. 1, 2003

Novel chemokine CCR4 receptor modulators and their use in asthma therapy

Aug. 29, 2003

AD-237 enters phase IIa study for COPD

Aug. 26, 2003

New safety information for salmeterol-based drugs

Aug. 21, 2003

Potent and selective non-imidazole human histamine H4 receptor antagonists

Aug. 18, 2003

Phase II DCF-987 trial completes enrollment

Aug. 13, 2003

Novel series of Syk kinase inhibitors covered by Boehringer Ingelheim patent

Aug. 13, 2003

NexMed enters NexACT R&D agreement for asthma

Aug. 12, 2003

Bimosiamose decreases LAR in asthmatics following allergen challenge

Aug. 7, 2003

Two series of adenosine A3 receptor antagonists described by Sanofi-Synthelabo

Aug. 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...